CVS to Cover Lilly’s GLP-1 Medications, Expanding Access
CVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Overview of annual performance metrics for index funds highlights consistency and risk-adjusted returns to inform choices.
21,807 articlesCVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
ServiceNow climbs as investors chase AI-driven growth in enterprise software, with Dell's recent results helping lift...
As markets wobble in 2026, investors favor a two-bucket plan that locks in $5,000 in monthly income and preserves cap...
XRP trades near a 15-week low around $1.30 as ETF demand remains steady while on-chain withdrawals intensify, signali...
A distressed retailer trading under $15 is drawing new attention as improving cash flow and debt reduction point to a...
Archer Aviation stock popped last month as investors weighed milestones in eVTOL development, defense partnerships, a...
When a company with a big run sees a director trim shares, investors naturally ask what comes next. This guide breaks...
Investing headlines love bold predictions, but long-term numbers rarely align with hype. This guide uses SpaceX as a ...
A leaked document outlines a SpaceX strategy to move AI compute to orbit, potentially reshaping investment bets acros...
May 2026 data show mortgage lock volume slid 9% from April as higher rates cooled demand. Purchases led the market, w...
Curve rolls out Llamalend v2 on Optimism, expanding collateral and borrowing options. The upgrade comes with a 250,00...
Anthropic unveils a $150 million fellowship to place 1,000 AI coaches with nonprofits for a year, funded as the compa...